Australia Markets close in 2 hrs 7 mins

Comera Life Sciences Holdings, Inc. (CMRA)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.8975+0.0135 (+1.53%)
At close: 01:33PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close0.8840
Open0.8840
Bid0.8750 x 2200
Ask0.9200 x 900
Day's range0.8705 - 0.9625
52-week range0.8700 - 15.3000
Volume1,998
Avg. volume60,367
Market cap19.983M
Beta (5Y monthly)1.06
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    Comera Life Sciences Reports Financial Results for Fourth Quarter and Full Year 2022 and Recent Business Highlights

    – Extended and broadened its ongoing research collaboration with Regeneron, a leading U.S. biotechnology company – – Announced CLS-001 as subcutaneous formulation of vedolizumab, a currently marketed monoclonal antibody for the treatment of inflammatory bowel disease (IBD) – – Joined the Subcutaneous Drug Development & Delivery Consortium (SC Consortium) to advance the science, technology, and best practices for subcutaneous (SQ) drug development and delivery – WOBURN, Mass., March 16, 2023 (GLO

  • GlobeNewswire

    Comera Life Sciences to Present at 22nd Annual PepTalk Conference

    WOBURN, Mass., Jan. 12, 2023 (GLOBE NEWSWIRE) -- Comera Life Sciences Holdings, Inc. (Nasdaq: CMRA) (“Company” or “Comera”), a life sciences company developing a new generation of bio-innovative biologic medicines to improve patient access, safety and convenience, today announced it will present at the 22nd Annual PepTalk Conference, in San Diego on Wednesday, Jan. 18, 2023 at 5:15 p.m. PT. The conference will run from Monday, Jan. 16 through Friday, Jan. 20. Subhashchandra Naik, Ph.D., Senior R

  • GlobeNewswire

    Comera Life Sciences to Present at Upcoming Biotech Showcase Investor Conference

    WOBURN, Mass., Jan. 05, 2023 (GLOBE NEWSWIRE) -- Comera Life Sciences Holdings, Inc. (Nasdaq: CMRA), a life sciences company developing a new generation of bio-innovative biologic medicines to improve patient delivery, access, safety and convenience, today announced that the company will present at the upcoming Biotech Showcase Conference on Tuesday, January 10, 2023 at 9:00 AM PT in San Francisco, CA. The Company will also host one-on-one meetings with investors from Monday, January 9 through W